“…It leads to mobility disabilities with poor life quality and increased health care and social needs for the elderly (Iannuzzi-Sucich et al, 2002). These pathological states share unique features and are all characterized by a loss of collagen type I, dysregulated fibroblast-matrix interactions and impaired fibroblast interactions with organ parenchyma, mainly with organ-specific epithelial cells and muscle (Wenk et al, 1999(Wenk et al, , 2004Krtolica & Campisi, 2002;Campisi, 2005;Labat-Robert & Robert, 2007;Treiber et al, 2009). A variety of genetic and environmental factors including increased concentration of ROS, mitochondrial dysfunction (Hiona & Leeuwenburgh, 2008), changes in autocrine, paracrine and endocrine release of hormones, growth factors (Perrini et al, 2010) and cytokines (Coppe et al, 2008) have been identified to contribute to skin aging, sarcopenia and osteoporosis in humans and rodents (Zofkova, 2003;Raisz, 2005;Ralston & de Crombrugghe, 2006;Hiona & Leeuwenburgh, 2008;Marzetti et al, 2009).…”